Clinical Trial Update: CAFE Comparison of Atypicals in First Episode of Psychosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atypical antipsychotics in first-episode psychosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED